Updated ESH position paper on interventional therapy of resistant hypertension.

@article{Schmieder2013UpdatedEP,
  title={Updated ESH position paper on interventional therapy of resistant hypertension.},
  author={Roland E Schmieder and Josep Redon and Guido Grassi and Sverre Erik Kjeldsen and Giuseppe Mancia and Krzysztof Narkiewicz and Gianfranco Parati and Luis Ruilope and Philippe van de Borne and Konstantinos Tsioufis},
  journal={EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology},
  year={2013},
  volume={9 Suppl R},
  pages={R58-66}
}
Out of the overall hypertensive population it is estimated that approximately 10% have treatment resistant hypertension (TRH). Percutaneous catheter-based transluminal renal ablation (renal denervation [RDN] by delivery of radiofrequency energy) has emerged as a new approach to achieve sustained blood pressure reduction in patients with TRH. This innovative interventional technique is now available across Europe for severe TRH for those patients in whom pharmacologic strategies and lifestyle… CONTINUE READING